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H. FUNDING
The work was supported through multiple national and international government agencies and cancer charities Acknowledgement of research support: EURAMOS-1 is an academic clinical trial funded through multiple national and international government agencies and cancer charities. 
H1. Role of the funding sources
Funding for this academic trial was provided by governmental and charitable bodies in each participating country, with additional funding for pan-European trial co-ordination.
Funding bodies are listed in the Appendix. Pegylated interferon-α2b was provided by Merck and Co (formerly Schering-Plough), who reviewed the report. UK MRC and COG employees were central to trial design, trial conduct, data analysis, data interpretation and the development of this report. MS and GJ accessed raw data. The corresponding author had full access to the data and had final responsibility for the decision to submit for publication.
